Creative Medical Tech Stock (NASDAQ: CELZ) stock price, news, charts, stock research, profile.
You can purchase shares of Creative Medical Tech (NASDAQ:CELZ) through any online brokerage.
Other companies in Creative Medical Tech’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Can Fite Biofarma (AMEX:CANF), ABVC BioPharma (NASDAQ:ABVC), Portage Biotech (NASDAQ:PRTG) and TransCode Therapeutics (NASDAQ:RNAZ).
Creative Medical Tech has a consensus price target of $10.00.
The stock price for Creative Medical Tech (NASDAQ: CELZ) is $4.6501 last updated February 14, 2025 at 7:01 PM EST.
There are no upcoming dividends for Creative Medical Tech.
Creative Medical Tech’s Q1 earnings are confirmed for Friday, May 9, 2025.
There is no upcoming split for Creative Medical Tech.
Creative Medical Tech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.